A P-element is inserted within an intron inside RhoGAP18B.
RhoGAP18B3 mutants exhibit resistance to ethanol-induced sedation measured with either a locomotor tracking system or a loss-of-righting (LOR) test. Ethanol absorption is normal in RhoGAP18B3 flies, which also perform normally in various behavioural assays, including those measuring sensitivity to CO[[2]]-induced sedation, nicotine toxicity, spontaneous locomotion, circadian rhythms, and negative geotaxis. RhoGAP18B3 flies also show increased resistance to the acute effects of nicotine and cocaine.
RhoGAP18B3 mutants exhibit reduced viability (31% viability).
RhoGAP18B3 mutant flies exhibit significantly reduced loss-of-righting (LOR-refers to the inability of flies to regain upright posture upon mechanical stimulation) compared to control flies.
The brain structures of RhoGAP18B3 mutant flies do not seem morphologically different from wild-type.
RhoGAP18BNP1514 has partially lethal - majority die phenotype, suppressible by Arfip12/Arfip[+]
RhoGAP18BNP1514 has partially lethal - majority die phenotype, suppressible by Arf51F[+]/Arf6NP5226
RhoGAP18BNP1514 has partially lethal - majority die phenotype, suppressible by Efa6[+]/Efa6c00953
RhoGAP18BNP1514 is rescued by Scer\GAL4NP1514/RhoGAP18BRC.UAS
RhoGAP18BNP1514 is rescued by Scer\GAL4NP1514/RhoGAP18BRC.UAS
RhoGAP18BNP1514 is not rescued by Scer\GAL4NP1514/RhoGAP18BRC.UAS/Scer\GAL80ts.αTub84B
Expression of RhoGAP18BRC.Scer\UAS under the control of Scer\GAL4whir3 in RhoGAP18B3 mutant males results in nearly normal ethanol sedation. This behavioural rescue is manifested as a reduction in the time required for 50% of the flies to reach sedation. In addition, RhoGAP18BRC.Scer\UAS expression also increases the viability of the RhoGAP18B3 mutant from 31% to 83%.
Based on resistance to enthanol-induced sedation, the following RhoGAP18B alleles can be ranked from strongest to weakest as follows: RhoGAP18B3 > RhoGAP18B1 = RhoGAP18BΔRC.